Literature DB >> 8923077

An unusual cause for collapse in a patient with arthritis.

K J Heath1, M J Sampson, S A Ridley.   

Abstract

We present the clinical case of a patient who was admitted to the intensive care ward with severe central nervous system symptoms and cardiovascular collapse within a week of starting sulphasalazine; in the absence of any other diagnosis, these symptoms were felt to be due to a previously unreported adverse effect of sulphasalazine.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8923077     DOI： 10.1007/bf01699235

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


  5 in total

1.  Combined hepatotoxicity and neurotoxicity following sulphasalazine administration.

Authors:  M D Smith; G E Gibson; R Rowland
Journal:  Aust N Z J Med       Date:  1982-02

Review 2.  Sulfasalazine neurotoxicity: a report of aseptic meningitis and a review of the literature.

Authors:  J A Alloway; S R Mitchell
Journal:  J Rheumatol       Date:  1993-02       Impact factor: 4.666

3.  Sulfasalazine-associated encephalopathy in a patient with Crohn's disease.

Authors:  R Schoonjans; A Mast; G Van den Abeele; D Dewilde; E Achten; V Van Maele; W Pauwels
Journal:  Am J Gastroenterol       Date:  1993-10       Impact factor: 10.864

4.  Sulfasalazine induced seizures and dysphasia.

Authors:  M E Hill; C Gordon; R D Situnayake; D A Heath
Journal:  J Rheumatol       Date:  1994-04       Impact factor: 4.666

5.  Sulphasalazine for rheumatoid arthritis: toxicity in 774 patients monitored for one to 11 years.

Authors:  R S Amos; T Pullar; D E Bax; D Situnayake; H A Capell; B McConkey
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.